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The A-type and B-type lamins form a ﬁlamentous meshwork underneath the inner nuclear membrane
called the nuclear lamina, which is an important component of nuclear architecture in metazoan cells.
The lamina interacts with large, mostly repressive chromatin domains at the nuclear periphery. In ad-
dition, genome–lamina interactions also involve dynamic association of lamin A/C with gene promoters
in adipocytes. Mutations in the human lamin A gene cause a spectrum of hereditary diseases called the
laminopathies which affect muscle, cardiac and adipose tissues. Since most mutations in lamin A/C affect
skeletal muscle, we investigated lamin–chromatin interactions at promoters of muscle speciﬁc genes in
both muscle and non-muscle cell lines by ChIP-qPCR. We observed that lamin A/C was speciﬁcally as-
sociated with promoter regions of muscle genes in myoblasts but not in ﬁbroblasts. Lamin A/C dis-
sociated from the promoter regions of the differentiation speciﬁc MyoD, myogenin and muscle creatine
kinase genes when myoblasts were induced to differentiate. In the promoter regions of the myogenin
and MyoD genes, the binding of lamin A/C in myoblasts inversely correlated with the active histone
mark, H3K4me3. Lamin A/C binding on muscle genes was reduced and differentiation potential was
enhanced on treatment of myoblasts with a histone deacetylase inhibitor. These ﬁndings suggest a role
for lamina–chromatin interactions in muscle differentiation and have important implications for the
pathological mechanisms of striated muscle associated laminopathies.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The nuclear lamina is a ﬁlamentous network of proteins that
underlies the inner nuclear membrane and extends into the nu-
clear interior in metazoan cells, and is mainly composed of the
lamin proteins. Lamins belong to the type V intermediate ﬁlament
protein family and are of two types. The A-type lamins, lamin A
and C (splice isoforms of the lamin A gene, LMNA) are expressed in
most lineage-committed and differentiated cells while the B-type
lamins, lamin B1 and B2 (encoded by separate genes) are ex-
pressed in all somatic cells. Lamins are the major architectural
proteins of the nucleus and are involved in chromatin organisation
as well as organisation of various nuclear functions, in addition to
providing mechanical support to the nuclear envelope [1–4].
Mutations in lamins have been linked to a wide spectrum of
heritable diseases called laminopathies, which include muscular
dystrophies, cardiomyopathies, lipodystrophies and acceleratedB.V. This is an open access article u
591.
).aging disorders. Laminopathic cells exhibit widespread alterations
in chromatin organisation, histone epigenetic marks and gene
activation, emphasising the importance of lamins in nuclear
chromatin dynamics [1–4]. The lamina associates with chromatin
through large domains termed lamina-associated domains or
LADs, which contain mostly inactive genes and are located at the
nuclear periphery; lamina–chromatin interactions are likely to be
regulated by modiﬁed histones and gene regulatory proteins and
can be disrupted by inhibitors of histone deacetylases (HDACs) as
well as depletion of lamins [5,6]. In addition to anchoring large
regions of chromatin at the nuclear periphery, lamin A/C has also
been shown to associate with promoter regions of genes in adi-
pocyte stem cells in a recent study. The association of lamin A/C at
adipogenic genes is altered upon adipogenic differentiation, sug-
gesting its importance for lineage commitment [6]. However it is
not known whether lamin A/C associates with speciﬁc gene pro-
moters in other lineages such as muscle.
Since skeletal muscle is one of the major tissues affected by
mutations in lamin A/C, an understanding of lamin A/C–chromatin
interactions in muscle cells has important implications for disease
mechanisms of laminopathies. In the present study, we report ournder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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muscle-speciﬁc and non-muscle genes in mouse myoblasts and
differentiated myotubes, as well as ﬁbroblasts as an example of a
non-muscle cell type.2. Materials and methods
2.1. Cell culture and antibodies
C2C12 mouse myoblasts were maintained in DMEM supple-
mented with 20% FBS (growth medium, GM) and induced to dif-
ferentiate by transfer to DMEM containing 2% horse serum (dif-
ferentiation medium, DM) for 48 h [7]. NIH3T3 mouse ﬁbroblasts
were maintained in DMEM with 10% FBS. For sodium butyrate
treatment, proliferating myoblasts were cultured in GM containing
5 mM sodium butyrate (Sigma) for 24 h. A goat polyclonal anti-
body for lamin A/C (N-18, Santa Cruz Biotechnology) was validated
by chromatin immunoprecipitation (ChIP) followed by western
blotting as described earlier [8]. A ChIP-grade antibody to
H3K4me3 (07-473) was from Millipore Corporation.
2.2. Chromatin immunoprecipitation analysis
ChIP analysis was carried out by standard protocols. Brieﬂy 106
cells were cross-linked with 1% formaldehyde for 10 min at 37 °C
followed by quenching with 0.125 M glycine solution. Cells were
washed, lysed in lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris, pH
8.1) containing protease inhibitors and sonicated to shear chro-
matin into fragments less than 500 bp in size using Bioruptor
(Diagenode). Sheared chromatin was diluted with ChIP dilution
buffer (0.01% SDS, 1.1% Triton X-100, 2 mM EDTA, 20 mM Tris–HCl,
pH 8.1 and 167 mM NaCl containing protease inhibitors), pre-Fig. 1. Lamin A/C occupancy on promoters of MyoD1, Pax7 and Myf5. ChIP-qPCR analysis
myotubes differentiated for 48 h (solid bars) and NIH3T3 ﬁbroblasts (grey bars). Fold en
and (C)Myf5 promoter. (D) Percentage of input values for unspeciﬁc IgG and lamin A/C (L
are shown to indicate speciﬁcity of lamin A/C ChIP. (po0.05*, o0.01**).cleared and incubated overnight with lamin A/C antibody (3–4 μg)
or unspeciﬁc IgG at 4 °C. Following this the antigen–antibody
complexes were captured with pre-blocked protein A agarose and
washed sequentially with low salt (0.1% SDS, 1% Triton X-100,
2 mM EDTA, 20 mM Tris–HCl, pH 8.1, 150 mM NaCl), high salt (0.1%
SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris–HCl, pH 8.1,
500 mM NaCl) and LiCl wash buffers (0.25 M LiCl, 1% NP40, 1%
sodium deoxycholate, 1 mM EDTA, 10 mM Tris, pH 8.1) followed by
TE buffer (10 mM Tris HCl, 1 mM EDTA, pH 8.0). Antigen–antibody
complexes were eluted from agarose using 1 M NaHCO3 and 1%
SDS. The input samples and the eluates were reverse cross-linked
and proteinase treated. DNA was isolated and puriﬁed using the
phenol–chloroform–isoamyl alcohol method. Following sodium
acetate–ethanol precipitation, DNA was dissolved in 30 μl of water
and used for qRT-PCR using 7900HT thermal cycler (Applied Bio-
systems). Primers speciﬁc to different regions of gene promoters
were either designed or obtained from previous reports. Each
promoter region was analysed in triplicate qRT-PCR reactions per
experiment and three independent ChIP experiments were per-
formed. The data is presented as average fold enrichment over IgG,
and less than 3-fold enrichment is considered as weak or no
binding. Representative IgG ChIP levels have been shown for one
experiment in Fig. 1D. Statistical signiﬁcance was calculated using
Student's t-test. List of primers used is provided in the Supple-
mentary Table S1.
2.3. Real time transcript analysis
Total RNA was isolated from myoblasts, myotubes and sodium
butyrate treated myoblasts using the Trizol method. As per man-
ufacturer's instructions, 1–5 μg of DNase treated RNA was reverse
transcribed using Superscript II reverse transcriptase kit (Invitro-
gen). qRT-PCR was performed as described above. Each gene waswith lamin A/C antibody on promoters of myogenic genes in myoblasts (open bars),
richment over IgG7S.D is represented for (A) MyoD1 promoter, (B) Pax7 promoter
A) obtained at representative promoter regions (MyoD 0.64 kb and Pax7 3.1 kb)
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independent experiments were performed. RPLP0 (ribosome pro-
tein large, P0) was used as internal control as it is reported to be
one of the most suitable internal controls for myoblasts [9]. Sta-
tistical signiﬁcance was calculated using the Student's t-test. List of
primers used is provided in Table S2.
2.4. Immunoﬂuorescence microscopy
Cells were washed with phosphate buffered saline (PBS), ﬁxed
with 3.5% formaldehyde in PBS for 10 min at room temperature,
and permeabilised with 0.5% Triton-X 100 (vol/vol) for 6 min at
room temperature. After blocking with 0.5% gelatin in PBS for one
hour, cells were incubated with primary antibody to myogenin
(monoclonal antibody from Developmental Studies Hybridoma
Bank, University of Iowa, USA) diluted in PBS for 1–2 h followed by
Cy3-conjugated secondary antibody in PBS for an hour. Coverslips
were then mounted on glass slides in Vectashield (Vector labora-
tories, Burlingame, CA, USA) containing 1 μg/ml DAPI to visualise
the nucleus. Slides were scanned on a LSM510 META/NLD confocal
microscope (Carl Zeiss, Jena, Germany). For quantiﬁcation of la-
belled cells, more than n¼150 cells were counted per sample in at
least three independent experiments.Fig. 2. Lamin A/C occupancy on promoters of Myog and Mck. ChIP-qPCR analysis
with lamin A/C antibody on promoters of differentiation-speciﬁc genes in myo-
blasts (open bars), myotubes differentiated for 48 h (solid bars) and NIH3T3 ﬁ-
broblasts (grey bars). Fold enrichment over IgG7S.D is represented for promoter
regions of (A) Myog and (B) Mck (po0.01**).3. Results
In order to determine whether lamin A/C associates with
chromatin in muscle stem cells, we used the C2C12 mouse myo-
blast cell line which is extensively used as an in vitromodel system
to study the biology of muscle differentiation [7]. Chromatin was
isolated from proliferating myoblasts and after differentiation for
48 h and ChIP assays were performed with lamin A/C antibody and
unspeciﬁc IgG. Regulatory regions of important muscle regulatory
genes as well as non-muscle genes were analysed. Furthermore, to
determine the speciﬁcity of association of lamin A/C with muscle
genes, chromatin from the mouse ﬁbroblast cell line NIH3T3 was
also used. We chose to analyse lamin A/C binding at well-docu-
mented promoter regions previously reported to be epigenetically
regulated, as described below for each gene.
3.1. Association of lamin A/C with promoters of myogenic genes
MyoD is the master regulator of myogenesis and binds to and
regulates several loci in myogenic cells [10]. It is expressed in
proliferating cells and is upregulated and stabilised in differ-
entiating cells. The MyoD1 gene locus has been shown to migrate
from the nuclear periphery in myoblasts to the nuclear interior in
differentiating cells [11]. Three regions of the MyoD1 promoter
were analysed. The proximal promoter regions (0.39 and
0.64 kb) [12] showed higher lamin A/C association (3–5-fold) in
myoblasts which was signiﬁcantly reduced in myotubes and was
similar to unspeciﬁc IgG in NIH3T3 ﬁbroblasts. The MyoD1 en-
hancer termed the distal regulatory region (DRR) at 5.3 kb,
which is known to regulate expression of MyoD during post natal
skeletal myogenesis and muscle regeneration [13], did not show
signiﬁcant enrichment of lamin A/C binding in myoblasts, myo-
tubes or ﬁbroblasts (Fig. 1A). Thus the proximal promoter regions
of MyoD1 have reduced association with lamin A/C upon onset of
differentiation.
The paired-box transcription factor Pax7 is indispensable for
muscle satellite cell survival, maintenance and self-renewal
[14,15]. It is expressed in quiescent and proliferating myoblasts
and downregulated upon differentiation. Three regions of Pax7
promoter, the proximal promoter region (0.8 kb), the conserved
polycomb response element (PRE) consisting of GAGA richsequence and YY1 binding motif and the distal enhancer region
(12 kb) [16] were analysed for lamin A/C binding. A 10-fold en-
richment of lamin A/C was observed at proximal promoter region
(0.8 kb) of Pax7 in myoblasts but not in myotubes. Other regions
did not show signiﬁcant differences in lamin A/C binding between
myoblasts and myotubes and all three regions showed no asso-
ciation with lamin A/C in NIH3T3 ﬁbroblasts (Fig. 1B). At the Myf5
promoter, enrichment of lamin A/C binding was weak (3-fold),
and it did not vary between myoblasts and myotubes at all three
reported regulatory regions [17] that were tested (Fig. 1C).
The myogenin and muscle creatine kinase (MCK) genes are
muscle-speciﬁc and expressed only in differentiated cells [18].
Both these genes are silenced in proliferating myoblasts by histone
modiﬁcations and DNA methylation [19]. Importantly, mutations
in lamin A/C that cause Emery-Dreifus muscular dystrophy impair
differentiation and myogenin expression in C2C12 myoblasts
[20,21], and alter epigenetic marks at its promoter region [22]. Six
regions of Myog promoter both upstream and downstream of the
transcription start site (TSS at 0.196 kb) [19, 23] were analysed
for association with lamin A/C. Of these regions 1.5 kb and
þ1.6 kb are differentiation speciﬁc enhancer elements identiﬁed
in a genome wide ChIP study in C2C12 cell line [19]. All regions
showed signiﬁcantly higher association with lamin A/C in myo-
blasts (5–7 fold) where myogenin is not expressed. Lamin A/C
binding to these regions was not detectable in both myotubes and
NIH3T3 ﬁbroblasts (Fig. 2A). Thus a differentiation dependent la-
min A/C binding was clearly evident at the Myog promoter.
Fig. 4. Binding of histone activation mark H3K4me3 on muscle genes. ChIP-qPCR
analysis with antibody to active histone mark H3K4me3 on promoter regions of (A)
MyoD1 and (B) Myog in myoblasts (open bars) and myotubes (solid bars). Fold
enrichment over IgG7S.D is represented. (po0.05*, o0.01**).
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well characterised regulatory region shown to be epigenetically
regulated by polycomb complexes during muscle differentiation
[23,24]. At this region more than 5-fold enrichment of lamin A/C
was obtained over IgG in myoblasts where MCK is not expressed
(Fig. 2B). Lamin A/C binding was not seen in myotubes and also
undetectable in NIH3T3 ﬁbroblasts. A similar lamin A/C binding
proﬁle was not observed at the non-regulatory region adjacent to
the enhancer region at 3.1 kb.
3.2. Association of lamin A/C with non-muscle genes
We determined lamin A/C binding at a number of genes that
are usually silenced in either differentiated myotubes (cell cycle
genes) or in both myoblasts and myotubes (pluripotency and other
lineage speciﬁc genes). Enrichment of lamin A/C binding was less
than 3-fold at the cell cycle gene coding for cyclin D1 and the
pluripotency gene Oct3/4. However, regions upstream of TSS of the
pluripotency genes Nanog and Sox2 showed 2–3-fold higher
binding of lamin A/C in myoblasts when compared to myotubes.
Enrichment of lamin A/C binding at promoters of genes expressed
in different lineages was less than 3-fold and did not differ be-
tween muscle cells and ﬁbroblasts. PU.1/Sfpi is involved in he-
matopoiesis while FABP4 (fatty acid binding protein 4) and CEBPβ
(CCAAT/enhancer binding protein, beta) are involved in adipogenic
differentiation and are not expected to be expressed in C2C12 cells.
No signiﬁcant lamin A/C binding was observed at promoters of a
house-keeping gene like Gapdh or permanently repressed HoxB8
of the hox cluster of genes (Fig. 3).
3.3. Correlation of lamin A/C binding with epigenetic modiﬁcations
In order to determine whether lamin A/C dissociation from
promoter regions correlates with deposition of active histone
marks, we analysed the proﬁle of active histone mark H3K4me3
across two genes, MyoD1 and Myog during differentiation and
compared it with lamin A/C occupancy. At regions proximal to the
TSS both in MyoD1 and Myog, levels of H3K4me3 were higher in
myotubes when compared to myoblasts (Fig. 4A and B). This cor-
related with reduced lamin A/C occupancy at these regions in
myotubes which was observed in the previous experiment
(Figs. 1A and 2A).
Since our data suggests that lamin A/C may be involved in si-
lencing of differentiation speciﬁc genes in myoblasts, we examined
whether activation of these genes by inhibition of histone deace-
tylase activity might cause loss of lamin A/C binding from pro-
moter regions. Treatment of myoblasts with a histone deacetylase
inhibitor, sodium butyrate has been previously shown to enhance
their differentiation potential [25]. Analysis of Myog promoter re-
gions in sodium butyrate treated myoblasts showed loss of lamin
A/C occupancy from 1.5 kb, þ1.0 and þ1.6 kb promoter regions
(Fig. 5A). The Mck enhancer at 4.1 kb, MyoD1 promoter atFig. 3. Lamin A/C occupancy on promoters of non-muscle genes. ChIP-qPCR ana-
lysis with lamin A/C antibody on promoters of non-muscle genes in myoblasts
(open bars), myotubes differentiated for 48 h (solid bars) and NIH3T3 ﬁbroblasts
(grey bars). Fold enrichment over IgG7S.D is represented. (po0.05*, o0.01**).0.64 kb and Pax7 promoter at 0.83 kb also showed signiﬁcant
loss of lamin A/C binding (Fig. 5B–D). There was also a decrease in
the weak binding of lamin A/C to the þ1.4 kb Myf5 promoter
(Fig. 5E).
In order to examine the effects of sodium butyrate on tran-
scription of muscle genes in our experimental system, real time
transcript analysis was carried out with myoblasts, sodium buty-
rate treated myoblasts and myotubes. As seen in Table 1, sodium
butyrate treatment increased the transcript levels of the early
differentiation marker MyoD1 as well as Pax7, but the levels of
myogenin and the late marker MCK were not increased. The
transcript levels of Myf5 and the non-muscle speciﬁc gene cyclin
D1 which do not bind to lamin A/C were also not increased after
treatment. Upon differentiation of normal myoblasts, transcript
levels of MyoD, myogenin and MCK increased, while cyclin D1
decreased as expected; levels of Pax7 and Myf5 were also not
signiﬁcantly altered. Since expression of myogenin and MCK in
myoblasts is normally tightly repressed by different signalling
pathways [18,19], their levels in treated myoblasts were unlikely to
increase after treatment. However, sodium butyrate treatment of
myoblasts is known to enhance the differentiation capacity of
myoblasts after transfer to DM [25]. Consistent with this report,
when we analysed myogenin expression in differentiated cells by
immunoﬂuorescence assays, we observed a marked increase in
myogenin positive cells from 30% to 50% after treatment of
myoblasts with sodium butyrate (Fig. 5F).4. Discussion
In the present study, we show that lamin A/C associates with
distinct promoter regions of muscle-speciﬁc genes MyoD1, Myog
and Mck in myoblasts but not in ﬁbroblasts, and this interaction is
reduced upon differentiation when these genes are upregulated.
Lamin A/C binding negatively correlates with deposition of the
Fig. 5. Lamin A/C occupancy in myoblasts treated with sodium butyrate. ChIP-qPCR analysis with lamin A/C antibody on promoter regions of muscle genes in untreated
myoblasts (open bars) and myoblasts treated with 5 mM sodium butyrate in GM for 24 h (solid bars). Fold enrichment over IgG7S.D is represented for promoters of (A)
Myog, (B) Mck, (C) MyoD1, (D) Pax7 and (E) Myf5. (F) Quantiﬁcation of myogenin expression by immunoﬂuorescence analysis in normal myoblasts (MB), normal myoblasts
differentiated to myotubes in DM (MT), myoblasts treated with 5 mM sodium butyrate (tr MB) and then differentiated in DM in the absence of sodium butyrate (tr MB in
DM). (po0.05*).
Table 1
Real time transcript analysis of muscle genes.
Gene Myoblasts Myotubes (48 h) NIH3T3 Treated Myoblastsa
MyoD 1 3.8671.01 (*) NDb 5.7271.08 (*)
Pax7 1 1.2370.18 ND 2.9170.74 (*)
Myf5 1 1.2670.25 ND 1.1370.28
Myogenin 1 33.8076.05 (*) ND 2.0070.86
MCK 1 31.2774.33 (*) ND 1.0570.21
Cyclin D1 1 3.9670.40 (*) 2.7270.29 1.3570.21
Transcript levels 7S.D, normalised to levels in myoblasts are represented.
* po0.05.
a Myoblasts treated with 5 mM sodium butyrate.
b Not detectable.
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with an HDAC inhibitor.
The lamina interacts with large domains of mostly inactive
chromatin in LADs at the nuclear periphery in several cell types[5]. A recent report shows that lamin A/C also speciﬁcally associ-
ates with short promoter regions of speciﬁc genes in a differ-
entiation state dependent manner in adipocytes [6]. These chan-
ges in lamin A/C–promoter interactions were observed during
adipocyte differentiation and correlated with differential gene
expression [6], but were not examined in non-adipocyte cells. Our
results indicate that lamin A/C associates with the regulatory re-
gions of muscle genes that are important for induction of muscle
differentiation, and that this binding is reduced upon differentia-
tion of myoblasts to myotubes. However, the muscle-speciﬁc genes
that we tested were not bound by lamin A/C in NIH3T3 ﬁbroblasts
suggesting cell-type speciﬁcity of these lamin A/C–gene promoter
interactions. In addition to promoter proximal regions, we ob-
served that enhancer regions of few genes like Mck and Myog also
bind to lamin A/C in a differentiation speciﬁc manner. Recent
studies have demonstrated alterations in lamin A/C occupancy
with changes in histone modiﬁcation marks at gene regulatory
regions, and highlighted the importance of modiﬁed histones in
F. Athar, V.K. Parnaik / Biochemistry and Biophysics Reports 4 (2015) 76–82 81genome–lamina interactions [26–29]. A speciﬁc subset of lamin A/
C interacting domains or LiDs are enriched in repressive histone
marks and have higher gene density compared to lamin B1 in-
teracting domains [30]. A recent study reports that repressive
histone marks are replaced by active histone marks on inactive
genes associated with lamin A/C in response to insulin signalling,
and results in dissociation of lamin A/C followed by gene activation
[31]. We found that lamin A/C binding on Myog and MyoD1 pro-
moter regions inversely correlated with the active histone mark
H3K4me3, which marked these loci only in myotubes where Myog
and MyoD1 are upregulated. Furthermore, inhibition of HDACs by
sodium butyrate altered lamin A/C binding at promoter regions of
muscle genes, suggesting that an active chromatin structure may
not be compatible with lamin A/C binding. We also observed that
proximal and enhancer elements of different gene promoters
showed differences in levels of lamin A/C occupancy, suggesting
that lamin A/C may interact through speciﬁc gene sequences or
distinct combinations of repressive histone marks; this interaction
may occur directly or indirectly through speciﬁc binding proteins.
Although we cannot rule out the possibility that lamin A/C inter-
actions could be partly stochastic, overall our data suggests that
lamin A/C binding is important for repressing the expression po-
tential of differentiation-speciﬁc genes in myoblasts.
It has been reported that lamin A/C binding does not strictly
correlate with gene silencing and approximately 20% of genes in
lamin A/C associated domains are still actively transcribed
[6,32,33]. We detected increased binding of lamin A/C at the
proximal promoter region of Pax7 in myoblasts where it is ex-
pressed and lower binding in myotubes where the expression in
shut down. We also noted that lamin A/C is bound to the inactive
Nanog and Sox2 loci in myoblasts but is dissociated in myotubes
and ﬁbroblasts although these loci remain inactive in these cells.
The Nanog locus is also bound to lamin A/C in adipose stem cells
[6]. Importantly, muscle gene promoters are not bound to lamin A/
C in ﬁbroblasts though these genes are not expressed in ﬁbro-
blasts. These ﬁndings raise questions about the precise role of la-
min–promoter interactions in different cell types and more ex-
tensive analysis on a genome-wide scale with different cell types
is required to clarify some of these issues.
Based on our ﬁndings, we propose that muscle differentiation
cues that regulate the deposition of active histone marks in place
of repressive histone marks at promoters of muscle regulatory
genes also mediate the dissociation of lamin A/C from these pro-
moters upon differentiation. We further suggest that lamin asso-
ciation with differentiation-speciﬁc gene promoters may be im-
portant for active repression of these genes in lineage committed
stem cells and might help to ﬁne-tune their expression potential.
Hence lamin binding at promoters might not be a default re-
pressive mechanism.
Mutations in the human lamin A gene cause striated muscle
laminopathies, where diseased cells fail to express muscle-speciﬁc
genes and are differentiation defective [1–4]. Our study indicates
that lamin A/C–promoter interactions vary in a differentiation
dependent manner in muscle cells and these alterations may have
roles in gene regulation during differentiation. Understanding
these interactions and their consequences are likely to provide
insights into disease mechanisms associated with laminopathies.Acknowledgements
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